MicroRNA-320a promotes 5-FU resistance in human pancreatic cancer cells
2016 · Scientific Reports · 85 citations
https://doi.org/10.1038/srep27641
W
Weibin Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
136
Papers
2.2K
Citations
26
h-index
43
i10-index
Weibin Wang is an academic researcher from Yunnan Agricultural University. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Pancreatitis Pathology and Treatment & RNA modifications and cancer. The author has an h-index of 26, co-authored 116 publications.
ORCID: 0000-0002-6659-9680Papers by this author
worksReview of the possible association between thyroid and breast carcinoma
2018 · World Journal of Surgical Oncology · 47 citations
https://doi.org/10.1186/s12957-018-1436-0
Global, regional, and national burden of pancreatic cancer from 1990 to 2021, its attributable risk factors, and projections to 2050: a systematic analysis of the global burden of disease study 2021
2025 · BMC Cancer · 36 citations
https://doi.org/10.1186/s12885-025-13597-z
Hypoxia inducible BHLHB2 is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma
2010 · Biochemical and Biophysical Research Communications · 32 citations
https://doi.org/10.1016/j.bbrc.2010.09.070
Dynamic change of serum CA19–9 levels in benign and malignant patients with obstructive jaundice after biliary drainage and new correction formulas
2021 · BMC Cancer · 24 citations
https://doi.org/10.1186/s12885-021-08204-w
CHRNB2 represses pancreatic cancer migration and invasion via inhibiting β-catenin pathway
2022 · Cancer Cell International · 16 citations
https://doi.org/10.1186/s12935-022-02768-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat